MAST - Magnesium for Sickle Cell Acute Crisis in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

July 31, 2013

Conditions
Anemia, Sickle Cell
Interventions
DRUG

Magnesium Sulfate

Intravenous Magnesium Sulfate (100 mg/Kg, Max 2 gram/dose) 8 hourly.

DRUG

Normal Saline

Intravenous Placebo (Normal Saline in equivalent amount to magnesium sulfate 100 mg/Kg, Max 2 gram/dose) 8 hourly.

Trial Locations (1)

M5G 1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

The Physicians' Services Incorporated Foundation

OTHER

lead

The Hospital for Sick Children

OTHER

NCT00313963 - MAST - Magnesium for Sickle Cell Acute Crisis in Children | Biotech Hunter | Biotech Hunter